Key Features of the Intragraft Microenvironment that Determine Long-Term Survival Following Transplantation

In this review, we discuss how changes in the intragraft microenvironment serve to promote or sustain the development of chronic allograft rejection. We propose two key elements within the microenvironment that contribute to the rejection process. The first is endothelial cell proliferation and angiogenesis that serve to create abnormal microvascular blood flow patterns as well as local tissue hypoxia, and precedes endothelial-to-mesenchymal transition. The second is the overexpression of local cytokines and growth factors that serve to sustain inflammation and, in turn, function to promote a leukocyte-induced angiogenesis reaction. Central to both events is overexpression of vascular endothelial growth factor (VEGF), which is both pro-inflammatory and pro-angiogenic, and thus drives progression of the chronic rejection microenvironment. In our discussion, we focus on how inflammation results in angiogenesis and how leukocyte-induced angiogenesis is pathological. We also discuss how VEGF is a master control factor that fosters the development of the chronic rejection microenvironment. Overall, this review provides insight into the intragraft microenvironment as an important paradigm for future direction in the field.

[1]  M. Dimopoulos,et al.  VEGF directly suppresses activation of T cells from ovarian cancer patients and healthy individuals via VEGF receptor Type 2 , 2012, International journal of cancer.

[2]  H. Bøtker,et al.  Effect of Everolimus Introduction on Cardiac Allograft Vasculopathy—Results of a Randomized, Multicenter Trial , 2011, Transplantation.

[3]  Lei Xu,et al.  Normalization of the vasculature for treatment of cancer and other diseases. , 2011, Physiological reviews.

[4]  M. Daemen,et al.  Early loss of peritubular capillaries after kidney transplantation. , 2011, Journal of the American Society of Nephrology : JASN.

[5]  G. Mayer Capillary rarefaction, hypoxia, VEGF and angiogenesis in chronic renal disease , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[6]  L. Otterbein,et al.  Intraoperative Administration of Inhaled Carbon Monoxide Reduces Delayed Graft Function in Kidney Allografts in Swine , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[7]  K. Famulski,et al.  The Molecular Phenotype of Kidney Transplants , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[8]  P. Ganz,et al.  Effect of vascular endothelial growth factor and its receptor KDR on the transendothelial migration and local trafficking of human T cells in vitro and in vivo. , 2010, Blood.

[9]  L. Nie,et al.  VEGF Blockade Inhibits Lymphocyte Recruitment and Ameliorates Immune-Mediated Vascular Remodeling , 2010, Circulation research.

[10]  S. Staibano,et al.  Angiogenesis and lymphangiogenesis in bronchial asthma , 2010, Allergy.

[11]  T. Kawabe,et al.  Endothelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis. , 2010, American journal of respiratory cell and molecular biology.

[12]  D. Bishop,et al.  TGF-beta, IL-6, IL-17 and CTGF direct multiple pathologies of chronic cardiac allograft rejection. , 2010, Immunotherapy.

[13]  P. Halloran,et al.  Endothelial transcripts uncover a previously unknown phenotype: C4d-negative antibody-mediated rejection , 2010, Current opinion in organ transplantation.

[14]  D. Briscoe,et al.  Cutting Edge: Vascular Endothelial Growth Factor-Mediated Signaling in Human CD45RO+ CD4+ T Cells Promotes Akt and ERK Activation and Costimulates IFN-γ Production , 2009, The Journal of Immunology.

[15]  T. Morisaki,et al.  VEGFR2 is selectively expressed by FOXP3high CD4+ Treg , 2009, European journal of immunology.

[16]  E. Reed,et al.  Effect of Antibodies on Endothelium , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[17]  J. Bertram,et al.  Endothelial-myofibroblast transition contributes to the early development of diabetic renal interstitial fibrosis in streptozotocin-induced diabetic mice. , 2009, The American journal of pathology.

[18]  G. Jhangri,et al.  Endothelial Gene Expression in Kidney Transplants with Alloantibody Indicates Antibody‐Mediated Damage Despite Lack of C4d Staining , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[19]  A. Keegan,et al.  Lung vascular endothelial growth factor expression induces local myeloid dendritic cell activation. , 2009, Clinical immunology.

[20]  N. Ferrara Vascular Endothelial Growth Factor , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[21]  F. Schena,et al.  Conversion From Calcineurin Inhibitors to Sirolimus Maintenance Therapy in Renal Allograft Recipients: 24-Month Efficacy and Safety Results From the CONVERT Trial , 2009, Transplantation.

[22]  D. Basile,et al.  VEGF-121 preserves renal microvessel structure and ameliorates secondary renal disease following acute kidney injury. , 2008, American journal of physiology. Renal physiology.

[23]  E. Meijer,et al.  CD40-Induced Signaling in Human Endothelial Cells Results in mTORC2- and Akt-Dependent Expression of Vascular Endothelial Growth Factor In Vitro and In Vivo1 , 2008, The Journal of Immunology.

[24]  O. Dormond,et al.  mTOR-understanding the clinical effects. , 2008, Transplantation proceedings.

[25]  Kohei Miyazono,et al.  Snail is required for TGFβ-induced endothelial-mesenchymal transition of embryonic stem cell-derived endothelial cells , 2008, Journal of Cell Science.

[26]  J. Norman,et al.  Chronic hypoxia as a mechanism of progression of chronic kidney diseases: from hypothesis to novel therapeutics. , 2008, Kidney international.

[27]  D. Bernstein,et al.  Genetic Polymorphisms Impact the Risk of Acute Rejection in Pediatric Heart Transplantation: A Multi-Institutional Study , 2008, Transplantation.

[28]  T. Paavonen,et al.  Vascular endothelial growth factor in chronic rat allograft nephropathy. , 2008, Transplant immunology.

[29]  A. G. Betz,et al.  Neuropilin-1 Expression on Regulatory T Cells Enhances Their Interactions with Dendritic Cells during Antigen Recognition , 2008, Immunity.

[30]  D. Briscoe,et al.  Assessing the vascular effects of early erythropoietin use in pediatric renal transplant recipients , 2008, Nature Clinical Practice Nephrology.

[31]  D. Briscoe,et al.  Every allograft needs a silver lining. , 2007, The Journal of clinical investigation.

[32]  M. Zamora,et al.  Microvascular destruction identifies murine allografts that cannot be rescued from airway fibrosis. , 2007, The Journal of clinical investigation.

[33]  Liang Xie,et al.  Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. , 2007, Cancer research.

[34]  T. Rabelink,et al.  Peritubular endothelium: the Achilles heel of the kidney? , 2007, Kidney international.

[35]  Jordan S. Pober,et al.  Evolving functions of endothelial cells in inflammation , 2007, Nature Reviews Immunology.

[36]  Yuguang Jiang,et al.  Acute renal allograft rejection is associated with increased levels of vascular endothelial growth factor in the urine , 2007, Nephrology.

[37]  Dai Fukumura,et al.  Tumor microvasculature and microenvironment: targets for anti-angiogenesis and normalization. , 2007, Microvascular research.

[38]  Kenneth P. Roos,et al.  Autocrine VEGF Signaling Is Required for Vascular Homeostasis , 2007, Cell.

[39]  O. Dormond,et al.  The Effects of mTOR-Akt Interactions on Anti-apoptotic Signaling in Vascular Endothelial Cells* , 2007, Journal of Biological Chemistry.

[40]  Xueli Yuan,et al.  Endothelial-to-mesenchymal transition contributes to cardiac fibrosis , 2007, Nature Medicine.

[41]  J. D. de Fijter,et al.  New horizons in prevention and treatment of ischaemic injury to kidney transplants. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[42]  P. Musiani,et al.  Triggering CD40 on endothelial cells contributes to tumor growth , 2006, The Journal of experimental medicine.

[43]  P. Romeo,et al.  Dendritic Cells Can Turn CD4+ T Lymphocytes into Vascular Endothelial Growth Factor-Carrying Cells by Intercellular Neuropilin-1 Transfer1 , 2006, The Journal of Immunology.

[44]  David W. Johnson,et al.  Novel renoprotective actions of erythropoietin: New uses for an old hormone (Review Article) , 2006, Nephrology.

[45]  A. Choi,et al.  Protective effect of carbon monoxide in transplantation , 2006, Journal of cellular and molecular medicine.

[46]  Taro Matsumoto,et al.  Signal transduction via vascular endothelial growth factor (VEGF) receptors and their roles in atherogenesis. , 2006, Journal of atherosclerosis and thrombosis.

[47]  R. Mannon,et al.  Therapeutic Targets in the Treatment of Allograft Fibrosis , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[48]  M. Faronato,et al.  Semaphorin-3A is expressed by tumor cells and alters T-cell signal transduction and function. , 2006, Blood.

[49]  T. Rabelink,et al.  Angiogenesis and endothelial cell repair in renal disease and allograft rejection. , 2006, Journal of the American Society of Nephrology : JASN.

[50]  Z. Haskova,et al.  Vascular Endothelial Growth Factor-Induced Signaling Pathways in Endothelial Cells That Mediate Overexpression of the Chemokine IFN-γ-Inducible Protein of 10 kDa In Vitro and In Vivo1 , 2006, The Journal of Immunology.

[51]  Napoleone Ferrara,et al.  Angiogenesis as a therapeutic target , 2005, Nature.

[52]  H. Yoshiji,et al.  Function of the Vascular Endothelial Growth Factor Receptors Flt-1 and Flk-1/KDR in the Alloimmune Response In Vivo , 2005, Transplantation.

[53]  M. Shibuya,et al.  The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions. , 2005, Clinical science.

[54]  S. W. Robertson,et al.  Vascular endothelial growth factor impairs the functional ability of dendritic cells through Id pathways. , 2005, Biochemical and biophysical research communications.

[55]  R. Jain Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy , 2005, Science.

[56]  G. Russ,et al.  Early cyclosporine withdrawal from a sirolimus‐based regimen results in better renal allograft survival and renal function at 48 months after transplantation , 2005, Transplant international : official journal of the European Society for Organ Transplantation.

[57]  Bart Landuyt,et al.  Vascular Endothelial Growth Factor and Angiogenesis , 2004, Pharmacological Reviews.

[58]  D. Hicklin,et al.  Anti‐vascular endothelial growth factor receptor‐2 (Flk‐1/KDR) antibody suppresses contact hypersensitivity , 2004, Experimental dermatology.

[59]  D. Briscoe,et al.  TNP-470, an angiogenesis inhibitor, attenuates the development of allograft vasculopathy. , 2004, Transplantation.

[60]  R. Homer,et al.  Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung , 2004, Nature Medicine.

[61]  Hsiu‐Po Wang,et al.  Interleukin-6 increases vascular endothelial growth factor and angiogenesis in gastric carcinoma. , 2004, Journal of biomedical science.

[62]  M. Probst-Kepper,et al.  Frontline: Neuropilin‐1: a surface marker of regulatory T cells (Vol. 34(3) 2004, pp 623–630, DOI 10.1002/eji.200324799) , 2004 .

[63]  I. Cohen,et al.  Angiogenesis-Inflammation Cross-Talk: Vascular Endothelial Growth Factor Is Secreted by Activated T Cells and Induces Th1 Polarization , 2004, The Journal of Immunology.

[64]  Y. Mori,et al.  Mechanism for IL-1β-mediated Neovascularization Unmasked by IL-1βKnock-out Mice(Molecular Biology, Vascular 1 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society) , 2004 .

[65]  D. Mukhopadhyay,et al.  Neuropilin-1-mediated Vascular Permeability Factor/Vascular Endothelial Growth Factor-dependent Endothelial Cell Migration* , 2003, Journal of Biological Chemistry.

[66]  D. Mukhopadhyay,et al.  Proinflammatory functions of vascular endothelial growth factor in alloimmunity. , 2003, The Journal of clinical investigation.

[67]  A. Valujskikh,et al.  Emerging roles of endothelial cells in transplant rejection. , 2003, Current opinion in immunology.

[68]  P. Ganz,et al.  EXPRESSION PATTERNS OF VASCULAR ENDOTHELIAL GROWTH FACTOR IN HUMAN CARDIAC ALLOGRAFTS: ASSOCIATION WITH REJECTION , 2003, Transplantation.

[69]  M. Haubitz,et al.  ELEVATED NUMBERS OF CIRCULATING ENDOTHELIAL CELLS IN RENAL TRANSPLANT RECIPIENTS , 2003, Transplantation.

[70]  K. Alitalo,et al.  Angiopoietin-1 Protects Against the Development of Cardiac Allograft Arteriosclerosis , 2003, Circulation.

[71]  P. Mathieson,et al.  Steroid-sensitive nephrotic syndrome and vascular endothelial growth factor gene polymorphisms. , 2003, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[72]  Sunjay Jain,et al.  Sequential protocol biopsies from renal transplant recipients show an increasing expression of active TGF β , 2002, Transplant international : official journal of the European Society for Organ Transplantation.

[73]  D. Briscoe,et al.  Endothelial injury: cause and effect of alloimmune inflammation , 2002, Transplant infectious disease : an official journal of the Transplantation Society.

[74]  J. Wood,et al.  Vascular Endothelial Growth Factor Enhances Cardiac Allograft Arteriosclerosis , 2002, Circulation.

[75]  Olivier Hermine,et al.  A neuronal receptor, neuropilin-1, is essential for the initiation of the primary immune response , 2002, Nature Immunology.

[76]  M. Shibuya,et al.  Vascular Endothelial Growth Factor Is Necessary in the Development of Arteriosclerosis by Recruiting/Activating Monocytes in a Rat Model of Long-Term Inhibition of Nitric Oxide Synthesis , 2002, Circulation.

[77]  D. Briscoe,et al.  A rendezvous before rejection: Where do T cells meet transplant antigens? , 2002, Nature Medicine.

[78]  A. Krasinskas,et al.  Non-hematopoietic allograft cells directly activate CD8+ T cells and trigger acute rejection: An alternative mechanism of allorecognition , 2002, Nature Medicine.

[79]  L. Truong,et al.  Role of the microvascular endothelium in progressive renal disease. , 2002, Journal of the American Society of Nephrology : JASN.

[80]  D. Briscoe,et al.  Angiogenesis and Allograft Rejection , 2002 .

[81]  D. Mukhopadhyay,et al.  Flt-1-mediated Down-regulation of Endothelial Cell Proliferation through Pertussis Toxin-sensitive G Proteins, βγ Subunits, Small GTPase CDC42, and Partly by Rac-1* , 2002, The Journal of Biological Chemistry.

[82]  C. Mavroudis,et al.  Serum vascular endothelial growth factor as a surveillance marker for cellular rejection in pediatric cardiac transplantation. , 2002, Transplantation.

[83]  D. McDonald,et al.  Angiogenesis and remodeling of airway vasculature in chronic inflammation. , 2001, American journal of respiratory and critical care medicine.

[84]  D. Mukhopadhyay,et al.  Vascular Permeability Factor (VPF)/Vascular Endothelial Growth Factor (VEGF) Receptor-1 Down-modulates VPF/VEGF Receptor-2-mediated Endothelial Cell Proliferation, but Not Migration, through Phosphatidylinositol 3-Kinase-dependent Pathways* , 2001, The Journal of Biological Chemistry.

[85]  J. Hughes,et al.  Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function. , 2001, Journal of the American Society of Nephrology : JASN.

[86]  J. Hughes,et al.  Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1. , 2001, Journal of the American Society of Nephrology : JASN.

[87]  D. McDonald,et al.  Time course of endothelial cell proliferation and microvascular remodeling in chronic inflammation. , 2001, The American journal of pathology.

[88]  Janice A. Nagy,et al.  The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor , 2001, Nature Medicine.

[89]  S. Kanazawa,et al.  VEGF, basic-FGF, and TGF-β in Crohn's disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation , 2001, American Journal of Gastroenterology.

[90]  S. Kanazawa,et al.  VEGF, basic-FGF, and TGF-β in Crohn’s disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation , 2001 .

[91]  D. Walsh,et al.  Angiogenesis in the pathogenesis of inflammatory joint and lung diseases , 2001, Arthritis research.

[92]  N. Aoike,et al.  Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. , 2001, The Journal of allergy and clinical immunology.

[93]  L. Truong,et al.  Peritubular capillary loss is associated with chronic tubulointerstitial injury in human kidney: altered expression of vascular endothelial growth factor. , 2000, Human pathology.

[94]  D. Mukhopadhyay,et al.  Ligation of CD40 induces the expression of vascular endothelial growth factor by endothelial cells and monocytes and promotes angiogenesis in vivo , 2000 .

[95]  P. Ganz,et al.  The role of the graft endothelium in transplant rejection: Evidence that endothelial activation may serve as a clinical marker for the development of chronic rejection , 2000, Pediatric transplantation.

[96]  P. Carmeliet,et al.  Angiogenesis in cancer and other diseases , 2000, Nature.

[97]  S. Rafii,et al.  Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration. , 2000, The Journal of clinical investigation.

[98]  Sunjay Jain,et al.  The role of transforming growth factor beta in chronic renal allograft nephropathy. , 2000, Transplantation.

[99]  Napoleone Ferrara,et al.  Clinical applications of angiogenic growth factors and their inhibitors , 1999, Nature Medicine.

[100]  E. Duh,et al.  Vascular endothelial growth factor and diabetes: the agonist versus antagonist paradox. , 1999, Diabetes.

[101]  R. Jain,et al.  Angiogenesis in the huPBL-SCID model of human transplant rejection. , 1999, Transplantation.

[102]  Peter Shaw,et al.  The allogeneic response to cultured human skin equivalent in the hu-PBL-SCID mouse model of skin rejection. , 1999, Transplantation.

[103]  S. Abdulla Angiogenesis and inflammation , 1999 .

[104]  R. Busse,et al.  Vascular endothelial growth factor activates nuclear factor-kappaB and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells. , 1999, Diabetes.

[105]  G. Bishop,et al.  Vascular endothelial growth factor expression in human chronic renal allograft rejection. , 1999, Transplantation.

[106]  M Aguet,et al.  VEGF is required for growth and survival in neonatal mice. , 1999, Development.

[107]  F. Brasch,et al.  Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease. , 1999, Hepato-gastroenterology.

[108]  D. Carbone,et al.  Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo. , 1998, Blood.

[109]  N. Tamura,et al.  Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis. , 1998, Circulation.

[110]  G. Majno Chronic inflammation: links with angiogenesis and wound healing. , 1998, The American journal of pathology.

[111]  A. Lichtman,et al.  Interactions between T lymphocytes and endothelial cells in allograft rejection. , 1998, Current opinion in immunology.

[112]  S. Soker,et al.  Tumor Necrosis Factor-α Regulates Expression of Vascular Endothelial Growth Factor Receptor-2 and of Its Co-receptor Neuropilin-1 in Human Vascular Endothelial Cells* , 1998, The Journal of Biological Chemistry.

[113]  R K Jain,et al.  Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. , 1998, The Journal of investigative dermatology.

[114]  K. Plate,et al.  Vascular endothelial growth factor , 1997, Journal of Neuro-Oncology.

[115]  E. Abel Clinical applications of research on angiogenesis , 1996 .

[116]  M. Klagsbrun,et al.  Vascular endothelial growth factor and its receptors. , 1996, Cytokine & growth factor reviews.

[117]  R. Jain,et al.  During angiogenesis, vascular endothelial growth factor regulate natural killer cell adhesion to tumor endothelium , 1996, Nature Medicine.

[118]  G. Breier,et al.  The Vascular Endothelial Growth Factor Receptor Flt-1 Mediates Biological Activities , 1996, The Journal of Biological Chemistry.

[119]  R. Jain,et al.  Leukocyte-endothelial adhesion and angiogenesis in tumors , 1996, Cancer and Metastasis Reviews.

[120]  M. Suthanthiran,et al.  Intragraft TGF-β1 mRNA: A correlate of interstitial fibrosis and chronic allograft nephropathy , 1996 .

[121]  A. Mantovani,et al.  Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. , 1996, Blood.

[122]  Kenneth J. Hillan,et al.  Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene , 1996, Nature.

[123]  C. Orosz,et al.  Can graft endothelial cells initiate a host anti-graft immune response? , 1996, Transplantation.

[124]  W. Faulk,et al.  Vascular endothelial growth factor expression in transplanted human hearts. , 1995, Transplantation.

[125]  J. Stone,et al.  Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity , 1995, Nature Medicine.

[126]  S. Soker,et al.  Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: a potential role for T cells in angiogenesis. , 1995, Cancer research.

[127]  R. Strieter,et al.  THE ROLE OF CXC CHEMOKINES AS REGULATORS OF ANGIOGENESIS , 1995, Shock.

[128]  Janet Rossant,et al.  Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice , 1995, Nature.

[129]  D. Mukhopadhyay,et al.  Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation , 1995, Nature.

[130]  E. Manseau,et al.  Overexpression of vascular permeability factor (VPF/VEGF) and its endothelial cell receptors in delayed hypersensitivity skin reactions. , 1995, Journal of immunology.

[131]  N. Olsen,et al.  Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue , 1994, The Journal of experimental medicine.

[132]  A. Koch,et al.  Production of angiogenic activity by human monocytes requires an L-arginine/nitric oxide-synthase-dependent effector mechanism. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[133]  P. Libby,et al.  Interaction of the allogeneic state and hypercholesterolemia in arterial lesion formation in experimental cardiac allografts. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[134]  G. Haines,et al.  Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis. , 1994, Journal of immunology.

[135]  E. Keshet,et al.  Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis , 1992, Nature.

[136]  T. Allen,et al.  Transforming growth factor beta 1 promotes the differentiation of endothelial cells into smooth muscle-like cells in vitro. , 1992, Journal of cell science.

[137]  J. Fiddes,et al.  The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. , 1991, The Journal of biological chemistry.

[138]  D. Goeddel,et al.  Vascular endothelial growth factor is a secreted angiogenic mitogen. , 1989, Science.

[139]  R. Auerbach,et al.  Angiogenesis induction by CD-4 positive lymphocytes. , 1988, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[140]  D. Koshland Frontiers in immunology. , 1987, Science.

[141]  A. Koch,et al.  Induction of Neovascularization by Activated Human Monocytes , 1986, Journal of leukocyte biology.

[142]  R. Auerbach,et al.  Nature of the stimulus leading to lymphocyte-induced angiogenesis. , 1979, Journal of immunology.

[143]  R. Auerbach,et al.  Lymphocyte-induced angiogenesis: a quantitative and sensitive assay of the graft-vs.-host reaction , 1975, The Journal of experimental medicine.

[144]  A. McMahon,et al.  Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. , 2010, The American journal of pathology.

[145]  R. Kalluri,et al.  Conversion of vascular endothelial cells into multipotent stem-like cells , 2010, Nature Medicine.

[146]  Jung‐Sik Kim,et al.  Vascular endothelial growth factor-induced chemotaxis and IL-10 from T cells. , 2009, Cellular immunology.

[147]  Shin,et al.  Vascular Endothelial Growth Factor Is a Key Mediator in the Development of T Cell Priming and Its Polarization to Type 1 and Type 17 T Helper Cells in the Airways , 2009 .

[148]  Rakesh K. Jain,et al.  Taming vessels to treat cancer. , 2008, Scientific American.

[149]  H. Kikutani,et al.  Immune Semaphorins: Novel Features of Neural Guidance Molecules , 2008, Journal of Clinical Immunology.

[150]  Atsushi Kumanogoh,et al.  Semaphorins and their receptors in immune cell interactions , 2008, Nature Immunology.

[151]  Z. Haskova,et al.  Vascular endothelial growth factor-induced signaling pathways in endothelial cells that mediate overexpression of the chemokine IFN-gamma-inducible protein of 10 kDa in vitro and in vivo. , 2006, Journal of immunology.

[152]  N. Ferrara The role of VEGF in the regulation of physiological and pathological angiogenesis. , 2005, EXS.

[153]  D. Hicklin,et al.  Anti-vascular endothelial growth factor receptor-2 antibody accelerates renal disease in the NZB/W F1 murine systemic lupus erythematosus model. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[154]  M. Goddard,et al.  Angiogenesis occurs within the intimal proliferation that characterizes transplant coronary artery vasculopathy. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[155]  M. Klagsbrun,et al.  Neuropilin is a Mediator of Angiogenesis , 2004, Cancer and Metastasis Reviews.

[156]  H. Matsubara,et al.  Mechanism for IL-1 beta-mediated neovascularization unmasked by IL-1 beta knock-out mice. , 2004, Journal of molecular and cellular cardiology.

[157]  R. Geffers,et al.  Frontline: Neuropilin‐1: a surface marker of regulatory T cells , 2004, European journal of immunology.

[158]  P. Harden,et al.  Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection. , 2002, Journal of the American Society of Nephrology : JASN.

[159]  D. Mukhopadhyay,et al.  Flt-1-mediated down-regulation of endothelial cell proliferation through pertussis toxin-sensitive G proteins, beta gamma subunits, small GTPase CDC42, and partly by Rac-1. , 2002, The Journal of biological chemistry.

[160]  D. Mukhopadhyay,et al.  Ligation of CD40 induces the expression of vascular endothelial growth factor by endothelial cells and monocytes and promotes angiogenesis in vivo. , 2000, Blood.

[161]  M. Eaman Immune system. , 2000, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[162]  M. Wilhelm,et al.  Chronic rejection. , 1998, Transplantation proceedings.

[163]  S. Soker,et al.  Tumor necrosis factor-alpha regulates expression of vascular endothelial growth factor receptor-2 and of its co-receptor neuropilin-1 in human vascular endothelial cells. , 1998, The Journal of biological chemistry.

[164]  H. Dvorak,et al.  Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine. , 1997, EXS.

[165]  P. Polverini Role of the macrophage in angiogenesis-dependent diseases. , 1997, EXS.

[166]  R. Jain,et al.  During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium. , 1996, Nature medicine.

[167]  M. Suthanthiran,et al.  Intragraft TGF-beta 1 mRNA: a correlate of interstitial fibrosis and chronic allograft nephropathy. , 1996, Kidney international.

[168]  J. Folkman Angiogenesis in cancer, vascular, rheumatoid and other disease , 1995, Nature Medicine.

[169]  D. Arenberg,et al.  Interferon gamma-inducible protein 10 (IP-10), a member of the C-X-C chemokine family, is an inhibitor of angiogenesis. , 1995, Biochemical and biophysical research communications.

[170]  T. Allen,et al.  Pericyte differentiation. , 1995, Clinical orthopaedics and related research.

[171]  J. Folkman Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. , 1995, The New England journal of medicine.

[172]  B. Berse,et al.  Vascular Permeability Factor/endothelial Growth Factor (vpf/vegf): Accumulation and Expression in Human Synovial Fluids and Rheumatoid Synovial Tissue , 1994 .

[173]  S. Wahl,et al.  Inflammation and Repair , 1990 .

[174]  D S Machado,et al.  Transplantation immunology. , 1990, Immunology series.

[175]  A. Krensky,et al.  Microvascular destruction in renal transplant rejection. , 1989, Transplantation.

[176]  D. Wiseman,et al.  Macrophages, wound repair and angiogenesis. , 1988, Progress in clinical and biological research.

[177]  D. Kamp,et al.  Transforming growth factor-beta (TGF beta) is chemotactic for human monocytes and induces their expression of angiogenic activity. , 1988, Biochemical and biophysical research communications.

[178]  Daniel L. Feeback,et al.  Inflammation and Repair , 1987 .

[179]  H. Shepard,et al.  Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α , 1987, Nature.

[180]  R. Markwald,et al.  Sturctural analysis of endocardial cytodifferentiation. , 1975, Developmental biology.

[181]  U. Ekelund,et al.  A proposed method of bias adjustment for meta-analyses of published observational studies , 2010, International journal of epidemiology.